ARQUES Industries AG / Disposal 25.03.2008 Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- ARQUES sells chemicals company, Oxiris, to strategic investor - Second successful exit in 2008 - Transaction volume of approximately EUR 10.5 million - Net proceeds more than EUR 10 million after less than 9 months Starnberg, March 25, 2008 - ARQUES Industries AG (ISIN DE0005156004) has sold another of its subsidiaries, the chemicals company, Oxiris Chemicals S.A., Spain, to the Raschig Group, Ludwigshafen. The transaction volume amounts to EUR 10.5 million. The transaction is subject to the approval of the relevant cartel authorities. With effect May 1, 2007, ARQUES took over the antioxidant business from Degussa for a symbolic price and continued operations under the name of Oxiris. Within the context of the transaction the chemicals company, Raschig, now acquires the ultramodern production location at Sant Celoni near Barcelona. In November 2007 Raschig already took over the phenol antioxidants business at the Ludwigshafen location from Oxiris. Oxiris is a leading manufacturer of antioxidants which are used to protect products against negative influences such as oxidation, embrittlement, gumming, or changes in colour or smell. Raschig is a company with a long tradition situated in Ludwigshafen and operating in the chemicals, synthetics, Raschig Rings and roads segments. Raschig belongs to the USA industrial holding, PMC Global Inc. The buyer offers the employees and management of Oxiris Chemicals S.A. a sound environment with clear future prospects. After the successful sale of the building supplier, Missel, in February 2008, this transaction is already the second exit in 2008. At least four further exits are to follow the Oxiris transaction in the financial year 2008. 'The Oxiris sale is further proof of the success of the ARQUES business model. In a very short period ARQUES succeeded in organising the antioxidant business into its own company structure, to develop this structure operationally and turn it into a sellable entity', said Dr. Michael Schumann, chairman of the ARQUES Industries AG executive board. About ARQUES ARQUES Industries AG, Starnberg, (www.arques.de), is a business partner of conglomerates regarding company spin-offs and a turnaround specialist who focuses on the acquisition and the active restructuring of companies in transitional situations, in order to develop these, with its own team and own resources, to competitive enterprises with a positive yield. ARQUES revitalises its subsidiaries' potential for creating value for the benefit of all its stakeholders, taking on the relevant social responsibility. The shares of ARQUES Industries AG are traded in the regulated market (Prime Standard) of the Frankfurt Stock Exchange under the symbol 'AQU' (ISIN: DE0005156004) and are listed in the MDAX as of October 1, 2007. Contact ARQUES Industries AG Investor Relations & Corporate Communication Anke Lüdemann, CEFA/CIIA Email: luedemann@arques.de Public Relations Christian Schneider Email: schneider@arques.de Tel.: +49 (0) 8151/ 651 0 DGAP 25.03.2008 --------------------------------------------------------------------------- Language: English Issuer: ARQUES Industries AG Münchner Str. 15a 82319 Starnberg Deutschland Phone: +49 (0)8151 651-0 Fax: +49 (0)8151 651- 500 E-mail: info@arques.de Internet: www.arques.de ISIN: DE0005156004 WKN: 515600 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Hamburg, Düsseldorf, München, Stuttgart End of News DGAP News-Service ---------------------------------------------------------------------------
DGAP-News: ARQUES sells chemicals company, Oxiris, to strategic investor
| Source: EQS Group AG